The impact of psychosis and antipsychotic treatment on cardiovascular risk factors

被引：0
|
作者：
Dehelean, L. [1 ]
Draghici, A. [2 ]
Manea, M. [2 ,3 ]
Papava, I. [1 ]
Manea, M. [2 ,3 ]
机构：
[1] Victor Babes Univ Med & Pharm, Neurosci, Psychiat, Timisoara, Romania
[2] Timisoara Psychiat Clin, Psychiat 2, Timisoara, Romania
[3] I Hatieganu Univ Med & Pharm, Med Educ, Med Psychol, Cluj Napoca, Romania
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
D O I：
10.1016/S0924-977X(16)31602-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.043
引用
收藏
页码：S554 / S555
页数：2
相关论文
共 50 条
  • [1] Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis
    El Abdellati, Kawtar
    De Picker, Livia
    Morrens, Manuel
    [J]. FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [2] CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH PSYCHOSIS
    Eriksson, Sven V.
    OSby, U.
    Edman, G.
    Mannelid, D.
    Akselson, S.
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 51 - 51
  • [3] Antipsychotic Treatment in People at Clinical High Risk for Psychosis
    Di Lisi, Alessandro
    Pupo, Simona
    Menchetti, Marco
    Pelizza, Lorenzo
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (05) : 502 - 508
  • [4] Cardiovascular risk factors in chronic treatment with antipsychotic agents used in primary care
    Mundet-Tuduri, Xavier
    Iglesias-Rodal, Manuel
    Olmos-Dominguez, Carmen
    Bernard-Antoranz, M. Lluisa
    Martin, M. Isabel Fernandez-San
    Amado-Guirado, Ester
    [J]. REVISTA DE NEUROLOGIA, 2013, 57 (11) : 495 - 503
  • [5] A Review of Cardiovascular Risk Factors in Women with Psychosis
    Gonzalez-Rodriguez, Alexandre
    Seeman, Mary V.
    Guardia, Armand
    Natividad, Mentxu
    Roman, Eloisa
    Izquierdo, Eduard
    Monreal, Jose A.
    [J]. WOMEN, 2023, 3 (02): : 200 - 213
  • [6] Detection of cardiovascular risk factors in patients with psychosis
    Vinas, Lydia
    Fernandez, Maribel
    San Emeterio, Luisa
    Martin-Lopez, Luis M.
    [J]. ATENCION PRIMARIA, 2011, 43 (07): : 386 - 387
  • [7] SCREENING OF CARDIOVASCULAR RISK FACTORS IN PATIENTS ON ANTIPSYCHOTIC MEDICATION
    Cronin, Thomas
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (08): : E14 - E14
  • [8] BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment
    Cooper, Stephen J.
    Reynolds, Gavin P.
    Barnes, T. R. E.
    England, E.
    Haddad, P. M.
    Heald, A.
    Holt, R. I. G.
    Lingford-Hughes, A.
    Osborn, D.
    McGowan, O.
    Patel, M. X.
    Paton, C.
    Reid, P.
    Shiers, D.
    Smith, J.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (08) : 717 - 748
  • [9] Antipsychotic treatment in clinical high risk for psychosis: Iatrogenesis related to dopamine supersensitivity psychosis?
    Bastiampillai, Tarun
    Chan, Sherry Kit Wa
    Allison, Stephen
    Copolov, David
    Looi, Jeffrey C. L.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (01): : 97 - 97
  • [10] Cardiovascular disease risk factors in autistic adults: The impact of sleep quality and antipsychotic medication use
    Bishop, Lauren
    Charlton, Rebecca A.
    McLean, Kiley J.
    McQuaid, Goldie A.
    Lee, Nancy Raitano
    Wallace, Gregory L.
    [J]. AUTISM RESEARCH, 2023, 16 (03) : 569 - 579
12345